Rheumatology: Current Research
Open Access

Department of Rheumatology, Aurora Rheumatology and Immunotherapy Center, Franklin, WI, USA

Publications

• Short Commentry   
  Remember Your Ps: Some Considerations for Initial Testing and Ongoing Monitoring for Patients on DMARDs
  Author(s): Wells AF* and Haddad R
  
  The care of patients with rheumatic diseases including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis has been revolutionized with the introduction of biologic medications including tumor necrosis factor-α inhibitors (TNFi); interleukin-6 (IL-6) antagonists; interleukin-17 (IL-17) antagonists; B cell antagonists; T cell antagonists; and Janus kinase inhibitors (JAKI).. View More»
  DOI: 10.35248/2161-1149.20.10.265

  Abstract HTML PDF